- 1.Single-cell RNA sequencing reveals that myeloid S100A8/A9 is a novel regulator of the transition from adaptive hypertrophy to heart failure after pressure overload
- 2.Blocking VCAM-1 prevents angiotensin II-induced hypertension and vascular remodeling in mice
- 3.Hyperhomocysteinaemia Promotes Doxorubicin-Induced Cardiotoxicity in Mice
- 4.Metabolomics in combination with network pharmacology reveals the potential anti-neuroinflammatory mechanism of essential oils from four Curcuma species
- 5.A Pathogenic Role for FcγRI in the Immune Response against Chlamydial Respiratory Infection
- 6.Severe hypertriglyceridemia caused by Gpihbp1 deficiency facilitates vascular remodeling through increasing endothelial activation and oxidative stress
- 7.Low-Dose Gallic Acid Administration Does Not Improve Diet-Induced Metabolic Disorders and Atherosclerosis in Apoe Knockout Mice
“和元李记”由和元生物 (股票代码:688238) 和李记生物合资成立的,主营“李记生物”“Life-ilab”试剂品牌
返回



